Polyphor Ltd Revenue and Competitors
Estimated Revenue & Valuation
- Polyphor Ltd's estimated annual revenue is currently $21.7M per year.
- Polyphor Ltd's estimated revenue per employee is $143,000
Employee Data
- Polyphor Ltd has 152 Employees.
- Polyphor Ltd grew their employee count by -7% last year.
Polyphor Ltd's People
| Name | Title | Email/Phone |
|---|
Polyphor Ltd Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.8M | 27 | -4% | $15.7M | N/A |
#2 | $25.5M | 178 | -3% | N/A | N/A |
#3 | $1.4M | 22 | -50% | $21.2M | N/A |
#4 | $56.6M | 348 | 19% | $6M | N/A |
#5 | $6.3M | 56 | -21% | $216.8M | N/A |
#6 | $0M | 2 | 0% | $33.3M | N/A |
#7 | $33.3M | 233 | 0% | N/A | N/A |
#8 | $32.4M | 232 | -26% | $64.6M | N/A |
#9 | $30M | 215 | -22% | $46.8M | N/A |
#10 | $261.6M | 1407 | 15% | $75M | N/A |
What Is Polyphor Ltd?
We aim to become a leading pharma company focused on antibiotics and specialty diseases We are a clinical stage biopharmaceutical company based in Allschwil, Switzerland, and are focused on the discovery and development of antibiotics and other specialty pharma products for severe or life-threatening diseases. Polyphor was founded in 1996 and is a clinical stage biopharmaceutical company based in Allschwil, Switzerland, near Basel. It focuses on the development of macrocycle drugs that address antibiotic resistance and improve therapy outcomes in cancer.
keywords:N/A
N/A
Total Funding
152
Number of Employees
$21.7M
Revenue (est)
-7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Polyphor Ltd News
Gilead Sciences, Aradigm, Lupin Ltd., Polyphor, Insmed Incorporated, Pharmaero, Savara Pharmaceuticals, Joincare Pharmaceutical Group, Pharmaxis Ltd.,...
Atypical Chemokine Receptor 3 Market Forecast 2022-2030| Key Players ChemoCentryx Inc, Jyant Technologies Inc, Polyphor Ltd,. Market Size And Forecast.
MedImmune LLC; Polyphor Ltd. The report divides the market into the following types: Aerucin; EV-035; MEDI-3902; Panobacumab; Others.
Other Companies in Allschwil
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $126.1M | 410 | 9% | N/A |